Aquarius Surgical Technologies Inc. (C:ASTI)
Business Focus: Advanced Medical Equipment & Technology (NEC)
Dec 12, 2022 03:50 pm ET
Aquarius Announces Debt Settlement Agreement
MISSISSAUGA, ON / ACCESSWIRE / December 12, 2022 / Aquarius Surgical Technologies Inc. (CSE:ASTI), is pleased to announce that has entered into a Debt Settlement Agreement, to settle $196,000 of accrued debt by issuance of 3,920,000 common shares. The shares issued or will be subject to a four month hold period from the original issue date.
Mar 25, 2022 09:35 am ET
Aquarius Surgical Technologies Announces Share Issuance
TORONTO, ON / ACCESSWIRE / March 25, 2022 / Aquarius Surgical Technologies Inc. (CSE:ASTI) announces that it has issued 100,000 shares to each of four non-executive directors and to corporate officers, in compensation for services, for a total of 600,000 shares. All shares were issued at a stated price of $0.065 each. The shares were issued pursuant to the prospectus exemption contained in NI 45-106 s. 2.24 and are not subject to any restrictive hold period.
Sep 01, 2021 01:12 pm ET
Aquarius Surgical Technologies Provides Year End and Q1 Results
TORONTO, ON / ACCESSWIRE / September 1, 2021 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("ASTI" or "the Company") released its financial results for the three-month, first-quarter-period ending June 30, 2021. This follows the release of its year-end financial results for the period ending March 31, 2021. All amounts are displayed in Canadian dollars.
Aug 25, 2021 04:29 pm ET
CSE Bulletin: Reinstatement - Aquarius Surgical Technologies Inc. (ASTI)
Toronto, Ontario--(Newsfile Corp. - Le 25 août/August 2021) Effective immediately, Aquarius Surgical Technologies Inc. will be reinstated for trading.
Aug 25, 2021 04:10 pm ET
IIROC Trade Resumption - ASTI
VANCOUVER, BC, Aug. 25, 2021 /CNW/ - Trading resumes in:
Aug 06, 2021 11:08 am ET
CSE Bulletin: Suspensions
Toronto, Ontario--(Newsfile Corp. - Le 6 about/August 2021) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.
Aug 06, 2021 07:47 am ET
IIROC Trading Halt - ASTI
VANCOUVER, BC, Aug. 6, 2021 /CNW/ - The following issues have been halted by IIROC:
Jul 20, 2021 07:55 pm ET
Aquarius Provides an Update on the Anticipated Delay in Filing of Annual Financial Results for the Year Ended March 31, 2021
TORONTO, ON / ACCESSWIRE / July 20, 2021 / Aquarius Surgical Technologies Inc. (CSE:ASTI)(the "Company") announces an update to the Press Release issued on July 19, 2021, when it announced that there is an anticipated delay in filing Annual Financial Results for the year ended March 31, 2021, and that an Application was being made to the Ontario Securities Commission for a Management Cease Trade Order pursuant to National Policy 12-203.
Jul 19, 2021 09:40 am ET
Aquarius Surgical Technologies Announces Anticipated Delay in Filing of Annual Financial Results for the Year Ended March 31, 2021
TORONTO, ON / ACCESSWIRE / July 19, 2021 / Aquarius Surgical Technologies Inc. (Ticker symbol - CSE:ASTI) ("ASTI" or the "Company") announces that, further to previous announcements in Press Releases dated February 22 and 25, and March 1 and 9, 2021, and as a result of the discovery of extensive fraudulent activities of Gordon Willox, a former director and officer, and other now-former executives and a now-former employee, the necessary work to complete the audit of the Annual Financial Statements and Management's Discussio
Mar 09, 2021 02:40 pm ET
Aquarius Surgical Technologies Announces Resignation of Gordon Willox and Provides Further Update in Relation to Irregular Activities Uncovered at Surgical Lasers Inc.
TORONTO, ON / ACCESSWIRE / March 9, 2021 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("ASTI" or the "Company") announces further developments following the announcement on February 22, 2021, that Gordon Willox ("Mr. Willox") had been removed as a director and officer of Surgical Lasers Inc. ("SLI"), the principal operating subsidiary of ASTI.
Mar 01, 2021 09:55 pm ET
Aquarius Surgical Technologies Reports Results of Operations for the Period Ending December 31, 2020
TORONTO, ON / ACCESSWIRE / March 1, 2021 / AQUARIUS SURGICAL TECHNOLOGIES INC. (CSE:ASTI) ("the Corporation") today reports the results of operations for the nine-month period ended December 31, 2020. All amounts referenced herein are in Canadian dollars.
Feb 26, 2021 08:31 am ET
IIROC Trade Resumption - ASTI
VANCOUVER, BC, Feb. 26, 2021 /CNW/ - Trading resumes in:
Feb 25, 2021 01:42 pm ET
Aquarius Surgical Technologies Provides Update in Relation to Irregular Activity Uncovered at Surgical Lasers Inc.
TORONTO, ON / ACCESSWIRE / February 25, 2021 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("ASTI" or the "Company") announces further developments following the announcement on February 22, 2021, that Gordon Willox ("Mr. Willox") had been removed as a director and officer of Surgical Lasers Inc. ("SLI"), the principal operating subsidiary of ASTI.
Feb 22, 2021 11:38 am ET
Aquarius Surgical Technologies Announces Removal of Gordon Willox as Director and Officer of Surgical Lasers Inc.
TORONTO, ON / ACCESSWIRE / February 22, 2021 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("ASTI" or the "Company") announces that Gordon Willox has been removed as a director of, and from all offices and positions in Surgical Lasers Inc., the wholly-owned operating subsidiary of the Company, with immediate effect. Steps will also be taken to remove Gordon Willox as a Director of ASTI at the earliest opportunity.
Feb 22, 2021 09:20 am ET
IIROC Trading Halt - ASTI
VANCOUVER, BC, Feb. 22, 2021 /CNW/ - The following issues have been halted by IIROC:
Oct 16, 2020 09:00 am ET
Aquarius Surgical Technologies Announces Appointment of John Bulicek as Vice President
TORONTO, ON / ACCESSWIRE / October 16, 2020 / Aquarius Surgical Technologies, Inc. (ASTI:CSE)(the "Company") is pleased to announce that John Bulicek has joined its business development team, as Vice President.
Jul 29, 2020 12:05 pm ET
Aquarius Surgical Technologies Announces Postponement of the Release of Annual Financial Statements and Related Disclosure due to COVID-19 related delays.
TORONTO, ON / ACCESSWIRE / July 29, 2020 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("the Company"), announces that there will be a delay in the filing of its annual financial statements and accompanying management's discussion and analysis, and related CEO and CFO certifications for the financial year ended March 31, 2020 (collectively "Annual Filings") due to COVID-19 related delays.
Jul 13, 2020 07:00 am ET
Aquarius Surgical Technologies Provides an Update on Business Operations and New Sales
TORONTO, ON / ACCESSWIRE / July 13, 2020 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("ASTI" or "the Company"), an exclusive provider of disruptive surgical laser systems in the field of urology, is moving forward with new laser and fiber sales as ASTI's minimally invasive surgeries have been classified as essential procedures, specifically for patients who have issues associated with potential kidney failure or urinary retention.
Jun 08, 2020 11:30 am ET
Aquarius Surgical Technologies Provides an Update on Its Operational Activities
TORONTO, ON / ACCESSWIRE / June 8, 2020 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("ASTI" or "the Company"), an exclusive provider of disruptive surgical laser systems in the field of urology, today provides a corporate update.
Apr 07, 2020 07:00 am ET
Aquarius Surgical Technologies Announces Covid-19 Support Program for Current and Prospective Clients
TORONTO, ON / ACCESSWIRE / April 7, 2020 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("ASTI" or "the Company"), an exclusive provider of disruptive surgical laser systems in the field of urology, today announced that it is sponsoring two unique programs related to COVID-19, which will give surgery centres and hospitals immediate access to the equipment required to deliver essential urinary procedures.
Mar 09, 2020 07:30 am ET
Aquarius Surgical Technologies Provides an Update on Its Operational Activities
TORONTO, ON / ACCESSWIRE / March 9, 2020 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("ASTI" or "the Company") is pleased to provide an update on its recent business advancements.
Feb 03, 2020 07:30 am ET
Aquarius Surgical Technologies Announces Rollover of a Short-Term Loan into a Convertible Note
TORONTO, ON / ACCESSWIRE / February 3, 2020 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("ASTI" or "the Company"), an exclusive provider of innovative, minimally invasive medical laser systems and consumables for multiple medical disciplines in the field of urology, today announced that one of its long-standing investors has agreed to exchange his 15% unsecured short-term loan of C$250,000, which matured on December 31, 2019, for a 9.5% unsecured convertible note maturing April 15, 2022.
Dec 02, 2019 12:35 pm ET
Aquarius Surgical Technologies Closes First Tranche of Private Placement
TORONTO, ON / ACCESSWIRE / December 2, 2019 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("Aquarius" or "the Company") today has completed the first tranche of a Private Placement announced in the November 1, 2019 Press Release.
Nov 26, 2019 11:26 am ET
Aquarius Surgical Technologies Reports Increased Sales in the First Half of 2020
TORONTO, ON / ACCESSWIRE / November 26, 2019 / Aquarius Surgical Technologies Inc. (CSE:ASTI) ("ASTI" or "the Company"), an exclusive provider of innovative, minimally invasive medical laser systems and consumables for multiple medical disciplines in the field of urology, today announced financial results for the six-month period ended September 30, 2019. The full report is available on www.SEDAR.com.
Nov 07, 2019 12:08 pm ET
Aquarius Surgical Technologies Offers Unique Equipment Financing Through a Partnership with Dext Capital
TORONTO, ON / ACCESSWIRE / November 7, 2019 / Aquarius Surgical Technologies Inc. (ASTI:CSE) ("ASTI" or "the Company"), the exclusive provider of a disruptive surgical laser system in the field of urology, is pleased to announce that it has forged a strategic partnership with Dext Capital Inc. ("Dext"), a leading US independent lessor focused on the healthcare industry. Dext will launch a unique healthcare leasing solution for ASTI's urology laser produc
Nov 01, 2019 10:06 am ET
Aquarius Surgical Technologies Announces Proposed Placement
TORONTO, ON / ACCESSWIRE / November 1, 2019 / Aquarius Surgical Technologies Inc. (ASTI:CSE) announces that it is initiating a non-brokered Private Placement offering of Units to raise a minimum of $250,000 and up to a maximum of $3 million from accredited investors. Each Unit in this proposed placement will be priced at $0.35, and will comprise one fully paid common share and one-half of a share purchase warrant; each whole share purchase warrant will entitle the holder to purchase one additional share at a price of $0.70 during the period up to thirty months from the closing da
Oct 07, 2019 01:45 pm ET
Aquarius Surgical Technologies Announces Proposed Placement
TORONTO, ON / ACCESSWIRE / October 7, 2019 / Aquarius Surgical Technologies Inc. (CSE:ASTI) announces that it is initiating a non-brokered Private Placement offering of Units to raise a minimum of $500,000 and up to a maximum of $3 million from accredited investors. Each Unit in this proposed placement will be priced at $0.35, and will comprise one fully paid common share and one-half of a share purchase warrant; each whole share purchase warrant will entitle the holder to purchase one additional share at a price of $0.70 during the period up to thirty months fro
Sep 12, 2019 07:00 am ET
Aquarius Surgical Technologies Provides an Update on Its Operational Activities
TORONTO, ON / ACCESSWIRE / September 12, 2019 / Aquarius Surgical Technologies Inc. (ASTI:CSE) (“ASTI” or “the Company”) is pleased to announce that Camp Lejuene, a naval hospital in North Carolina, has committed to the purchase of ASTI’s HYPHO laser device, following a successful comprehensive clinical evaluation made by ASTI’s newly signed distributor, Med Resources Inc.
Aug 28, 2019 10:10 am ET
Aquarius Surgical Technologies Reports Increased Sales in the First Quarter of 2020
TORONTO, ON / ACCESSWIRE / August 28, 2019 / Aquarius Surgical Technologies Inc. (CSE:ASTI) (“ASTI” or “the Company”), an exclusive provider of innovative, minimally invasive medical laser systems and consumables for multiple medical disciplines in the field of urology, today announced financial results for the three-month period ended June 30, 2019. The full report is available on www.SEDAR.com.
Aug 26, 2019 09:38 am ET
Aquarius Surgical Technologies Signs a Distribution Agreement with MedResources Inc., Expanding Its US Sales
TORONTO, ON / ACCESSWIRE / August 26, 2019 / Aquarius Surgical Technologies Inc. (CSE:ASTI) (“ASTI” or “the Company”) is pleased to announce that it has signed a long-term distribution agreement with MedResources Inc. (“MedResources”), a leading US medical device distributor serving the states of North and South Carolina. This partnership will add to the current sales of the Company, opening up an opportunity for ASTI to expand the sales of its laser technology to the new states.
Aug 09, 2019 02:57 pm ET
Aquarius Surgical Technologies Announces Proposed Placement
TORONTO, ON / ACCESSWIRE / August 9, 2019 / Aquarius Surgical Technologies Inc. (ASTI: CSE) announces that it is initiating a non-brokered Private Placement offering of Units to raise a minimum of $500,000 and up to a maximum of $2.5 million from accredited investors. Each Unit in this proposed placement will be priced at $0.35, and will comprise one fully paid common share and one-half of a share purchase warrant; each whole share purchase warrant will entitle the holder to purchase one additional share at a price o
Jun 27, 2019 07:00 am ET
Aquarius Surgical Technologies Closes First Tranche of Private Placement
TORONTO, ON / ACCESSWIRE / June 27, 2019 / Aquarius Surgical Technologies Inc. (CSE: ASTI) ("Aquarius" or "the Company") today has completed the first tranche of a Private Placement announced in the June 13, 2019 Press Release.
Jun 13, 2019 04:00 pm ET
Aquarius Surgical Technologies Announces Proposed Placement
TORONTO, ON / ACCESSWIRE / June 13, 2019 / Aquarius Surgical Technologies Inc. (ASTI: CSE) announces that on June 12, 2019 it initiated a non-brokered Private Placement offering of Units to raise a minimum of $500,000 and up to a maximum of $3 million from accredited investors. Each Unit in this proposed placement will be priced at $0.35, and will comprise one fully paid common share and one-half of a share purchase warrant; each whole share purchase warrant will entitle the holder to purchase one additional share at a price of $0.70 during the period up to th
Mar 12, 2019 01:10 pm ET
Aquarius Surgical Technologies Provides an Update on its 2018 Operation Successes
NEWMARKET, ON / ACCESSWIRE / March 12, 2019 / Aquarius Surgical Technologies Inc. (CSE: ASTI) ("Aquarius" or "the Company") today provides an update on its progress for the year of 2018.
Feb 20, 2019 07:00 am ET
Aquarius Surgical Technologies Retains CHF Capital Markets
NEWMARKET, ON / ACCESSWIRE / February 20, 2019 / Aquarius Surgical Technologies Inc. (CSE: ASTI) ("Aquarius" or "the Company") today announced that it has engaged CHF Capital Markets ("CHF"), a highly-regarded Canadian investor relations and capital markets firm.
Nov 28, 2018 04:00 am ET
Aquarius Surgical Technologies Announces Appointment of Mr. Gordon Willox as President & CTO, and the Closing of Funding Transaction
Aquarius Surgical Technologies Inc. (ASTI – CSE) (“the Corporation”) is pleased to announce that Mr. Gordon Willox, has been appointed to the position of President and Chief Technical Officer. Mr. Willox had previously been Managing Director of the...
Aug 13, 2018 11:37 am ET
IIROC Trade Resumption - ASTI
VANCOUVER, Aug. 13, 2018 /CNW/ - Trading resumes in:
Aug 07, 2018 08:35 am ET
IIROC Trading Halt - ASTI; LVI
VANCOUVER, Aug. 7, 2018 /CNW/ - The following issues have been halted by IIROC:
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.